Swiss Round Table on Antibiotics

"Why do we need a pull incentive to push antibiotics onto the market?"

In the White Paper published today the Swiss Round Table on Antibiotics discusses innovative ways of paying for antibiotics. We conclude that paying higher prices per package will not set the right incentive. Switzerland should rather test annual payments of a fixed fair amount per product – as other countries have already done. Only by joining forces can we revitalise the global development of antibiotics – to the benefit of patients in Switzerland and worldwide.

The Swiss Round Table on Antibiotics will publish its white paper "Effective antibiotics for the Swiss health care system: today and in the future" on Monday, 25 March 2024. Further details can be found in the media release.

The Swiss Round Table on Antibiotics proudly highlights the articles in the February 2024 edition of the StAR Newsletter, which showcase two events we organised in commemoration of the World AMR Awareness Week (WAAW) 2023.

The Swiss Round Table on Antibiotics commemorated the 2023 World AMR Awareness Week with a special event for its members and guests from its wider ecosystem. The event took place on November 27 in the premises of Debiopharm International in Lausanne and was cordially opened by the president of the company, Mr. Thierry Mauvernay.

About 70 participants from academia, industry, medicine, and the public administration followed the presentations that started with insights in the clinical practice. Further speakers shed light on current challenges, opportunities and solutions along the entire pharmaceutical value chain from early research up to making new antibiotics available to the patients.

Antibiotics were the focus of this year's Swiss Pharma Science Day, organised by the Swiss Academy of Pharmaceutical Sciences (SAPhS).

The Swiss Round Table on Antibiotics supports Patricia von Falkenstein's request (Motion 21.4539) to create incentives to develop new antibiotics in Switzerland and bring them to market (pull incentives). 

On 31. May 2023 the Public Health Agency of Sweden (PHAS) published the final report about their alternative reimbursement model (a pull incentive) that was piloted from July 2020 to December 2022. See the Round Table's brief summary and the full report in Swedish. 

The fourth General Assembly of the Round Table on Antibiotics took place on 30 May 2023 at the Swiss Institute for Translational and Enterpreneurial Medicine (sitem-insel) in Bern.

Today the FOPH confirmed a contribution to advance the Round Table on Antibiotics’ (RTA) Pull project. This project addresses the two goals set forth by the Swiss Strategy of Antibiotic Resistance and by the 2022-2026 report on Federal Measures to Strengthen Biomedical Research and Technology, namely to promote the availability of first-choice antibiotics and the development of new antibiotics by means of innovative reimbursement models (pull incentives).

To mark the end of World Antimicrobial Awareness Week (WAAW) and the start of the winter session of the Swiss Parliament, we have published the Roadmap to a Swiss Pull Incentive Scheme for Novel Antibiotics.

On 10 November 2022, Swiss television SRF featured the Round Table on Antibiotics in its news programme 10vor10.

We are proud to finally launch our new website. We hope you enjoy reading it.

The Executive Board unanimously appointed Barbara Polek, lic.rer.pol., MSc. as Managing Director of the Round Table on Antibiotics on 13. September 2022. We are very excited to win and welcome an expert with almost 40 years experience in pharmaceutical industry who is keen to further our mission.

Our Managing Director, Barbara Polek, explains in an interview with Interpharma how the AMR challenges should be addressed.

The General Assembly took place on May 31, 2022, at the Swiss Institute for Translational Medicine (sitem-insel) in Bern. The most important decision was the confirmation to pursue the strategic path proposed by the Board.